Dr. Chirag Desai MBBS , MD (Medicine), DM (Oncology), DNB

Hemato-Oncology Clinic (HOC) Vedanta

32 Years Experience

Dr. Chirag Desai – Hemato Oncologist

MBBS, MD (Medicine), DM (Oncology), DNB

Professional Summary

Dr. Chirag J. Desai is Founder Director of Hemato-Oncology Clinic (HOC) Vedanta, Ahmedabad, with 32+ years as a leading Hemato-Oncologist specializing in blood cancers and solid tumors. First-batch DM (Oncology) graduate from GCRI (1993), he has led 75+ clinical trials, published 30+ papers, and advanced oncology protocols across India. Renowned for research-driven care, multidisciplinary tumor boards, and cancer awareness initiatives.[web:1][file:79]

Hospital Affiliation

Hemato-Oncology Clinic (HOC) Vedanta, Ahmedabad
Founder Director & Chief Consultant Hemato-Oncologist

  • State-of-the-art oncology/hematology facilities with advanced chemotherapy
  • Comprehensive tumor boards and clinical trial capabilities
  • Research-oriented treatment protocols and immunotherapy services

Specialization Areas

Hemato-Oncology (Blood Cancers)

  • Leukemias: AML, ALL, CML, CLL, hairy cell leukemia
  • Lymphomas: Hodgkin, NHL, lymphoblastic, T/B-cell, CNS lymphoma
  • Plasma cell disorders: multiple myeloma, Waldenström, amyloidosis
  • MDS, aplastic anemia, myeloproliferative neoplasms, TTP

Solid Tumor Oncology

  • Breast: triple-negative, HER2+, hormone-positive, neoadjuvant/adjuvant
  • Gynecological: ovarian, cervical, endometrial, vulvar cancers
  • Prostate: localized, metastatic, CRPC management
  • Head & neck, lung (SCLC/NSCLC, EGFR/ALK), GI cancers (gastric, colorectal)

Advanced Cancer Therapies

  • Chemotherapy (conventional/novel), targeted therapy, immunotherapy
  • Checkpoint inhibitors, combination protocols, tumor lysis management
  • Supportive/palliative oncology with symptom control

Clinical Research & Academic Excellence

  • Principal investigator in 75+ USFDA/EMEA trials, DSMB member
  • 30+ publications, editorial boards, thesis mentor for 35+ students
  • Invited faculty at major oncology conferences, CDSCO expert presenter
  • Former National Oncology Coordinator, Director at Apollo CBCC

Treatment Philosophy

  • Evidence-Based Protocols – latest international cancer guidelines
  • Personalized Medicine – molecular profiling and targeted selection
  • Multidisciplinary Care – tumor boards with surgeons/radiation oncologists
  • Clinical Trial Access – early-phase and registration studies
  • Community Education – prevention, early detection programs

Advanced Services

  • Cancer Diagnosis: Tumor profiling, genetic testing, biomarker analysis
  • Treatment Planning: Multidisciplinary tumor boards, risk stratification
  • Clinical Trials: Phase I-III, biosimilars, immunotherapy, vaccines
  • Supportive Care: Nutrition, pain management, psychological support

Support Services

  • Advanced chemotherapy/immunotherapy administration
  • Nutritional counseling, palliative care coordination
  • Cancer survivorship programs, second opinions
  • Community awareness and clinical trial enrollment

Reopine Consultation Details

Available Services:

  • ✅ First Opinion Consultations – Cancer diagnosis/treatment planning
  • ✅ Second Opinion Reviews – Complex hemato-oncology assessment
  • ✅ Blood Cancer Consultations – Leukemia/lymphoma management
  • ✅ Solid Tumor Planning – Breast/prostate/GI strategies
  • ✅ Clinical Trial Information – Latest oncology research access
  • ✅ Palliative Care Planning – Advanced cancer support

Languages Spoken:

  • English (Fluent)
  • Hindi (Fluent)
  • Gujarati (Native)

Book Your Consultation

Access world-class cancer care from India's leading hemato-oncologist with 32+ years experience. Dr. Chirag Desai offers expert consultations through Reopine's secure platform for blood cancers, solid tumors, and clinical trial opportunities. Request today for evidence-based oncology expertise and personalized treatment strategies.

Last Updated: November 2025
Profile prepared for Reopine

Yrs

Male

Female

Other

Attachment
    This is content box Two

    Date: 15 Feb 2026

    1. Nature of Services
      • I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
      • I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
    2. Teleconsultation Limitations
      • I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
      • I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
    3. Emergency Situations
      • I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
      • In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
    4. Cross-Border Consultations
      • I understand that all doctors on Reopine are licensed to practice in India only.
      • If I access the platform from outside India:
        • I agree that the consultation is deemed to have occurred in India under Indian law.
        • I accept full responsibility for compliance with my country’s local laws.
        • I waive any claim against Reopine in foreign jurisdictions.
      • The information provided during this consultation is for general health guidance and educational purposes only.
      • It is not a substitute for an in-person medical examination by a doctor licensed in your country.
      • The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
        • Consult a locally licensed physician before starting or changing any medication or treatment.
      • The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
    5. Data Privacy
      • I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
      • I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
    6. Payment, Refund & Liability
      • I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
      • I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
      • I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
    7. Consent & Acknowledgment

      By proceeding, I confirm that:

      1. I have read and understood the Terms & Conditions and this Consent Form.
      2. I voluntarily consent to teleconsultation via Reopine.
      3. I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.

    Patient’s Full Name:

    Signature: ____________________________

    Date: 15 Feb 2026

    Subcribe to our Newsletter

    Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.